Harbor Capital Advisors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Harbor Capital Advisors’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,099	Closed	-$225K	–	665
2023 Q1	$225K	Buy	+2,099	New	+$242K	0.07%	199

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Harbor Capital Advisors's RXDX Position: Q2 2023 in Review

Harbor Capital Advisors sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 2,099 shares — an estimated $225K sold.

Harbor Capital Advisors first reported a position in RXDX in Q1 2023 and held it in 1 quarter. The position peaked at $225K in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Harbor Capital Advisors reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Harbor Capital Advisors sold 2,099 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $225K.
Harbor Capital Advisors first reported a position in Prometheus Biosciences, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Harbor Capital Advisors's Prometheus Biosciences, Inc. Common Stock position peaked at $225K in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Harbor Capital Advisors's 13F filing for Q2 2023, filed 11 Jul 2023.